Novel Brominated and Organophosphate Flame Retardants and Type 2 Diabetes

Clinical trial NCT06239506 · UNKNOWN

Trial details

NCT number: NCT06239506
Sponsor: Xiaoling Guan
Status: UNKNOWN
Study type: OBSERVATIONAL

Type 2 Diabetes Novel Brominated Flame Retardants Organophosphate Flame Retardants Fasting Plasma Glucose

Start date: 2022-01-01
Primary completion: 2024-12-30
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.